Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 937–960 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Diabetes, Foot Ulcer
Interventions: Personalized Behavioral Intervention, Current Best Practice; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years and older
Enrollment: 406 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Surgical Wound Dehiscence, Traumatic Wounds
Interventions: Study Device Debridement, SOC Debridement; Device
Lead sponsor: Medaxis, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Bradenton, Florida

Conditions: Crohn's Disease, Ulcerative Colitis, Rectal Cancer, Colon Cancer, Colon Polyps, Rectal Polyps, Diverticulitis
Interventions: Hextend, Lactated Ringers; Drug
Lead sponsor: Corewell Health West; Other
Eligibility: 18 Years to 80 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Erosive Esophagitis, Reflux Esophagitis, Gastroesophageal Reflux Disease
Interventions: esomeprazole magnesium (oral medication); Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 39
States / cities: Alabaster, Alabama • Anaheim, California • Dinuba, California + 36 more

Conditions: Erosive Esophagitis, Reflux Esophagitis, GERD
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Head and Neck Cancer (H&N), Oral Mucositis (Ulcerative) Due to Radiation, Stomatitis (Oral Mucositis), Xerostomia Due to Radiotherapy, Radiation Toxicity
Interventions: ORAL CARE PRODUCT KIT; Other
Lead sponsor: UNCANCER LLC; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Clearwater, Florida

Conditions: Active Ulcerative Colitis
Interventions: BG9418 (Interferon beta-1a), Placebo; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 5
States / cities: Birmingham, Alabama • Lakewood, Colorado • Bristol, Connecticut + 2 more

Conditions: Wound Healing
Interventions: GSK1278863, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 7
States / cities: Castro Valley, California • Washington D.C., District of Columbia • Miami, Florida + 4 more

Conditions: Aphthous Ulcer
Interventions: PBM Therapy, Maalox plus Benadryl; Device · Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 5 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Colitis Ulcerative, Crohn Disease
Interventions: Not listed
Lead sponsor: Harvard School of Public Health (HSPH); Other
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetic Foot
Interventions: GAM501, Placebo, Standard of care; Biological · Other
Lead sponsor: Tissue Repair Company; Industry
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 29
States / cities: Montgomery, Alabama • Mesa, Arizona • Phoenix, Arizona + 24 more

Conditions: Chronic Diabetic Foot Ulcers
Interventions: ON101 Cream, Vehicle Cream; Drug · Other
Lead sponsor: Oneness Biotech Co., Ltd.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 14
States / cities: Mesa, Arizona • Carlsbad, California • Castro Valley, California + 11 more

Conditions: Stasis Dermatitis
Interventions: crisaborole ointment, vehicle ointment; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 45 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 4
States / cities: El Segundo, California • Lafayette, California • South San Francisco, California + 1 more

Conditions: Colitis, Ulcerative, Inflammatory Bowel Diseases, Crohn's Disease
Interventions: No intervention; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 9,573 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Ulcerative Colitis
Interventions: Mesalamine Once-Daily, Mesalamine Twice-Daily; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 18 Years and older
Enrollment: 1,027 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 233
States / cities: Athens, Alabama • Birmingham, Alabama • Dothan, Alabama + 205 more

Conditions: Venous Leg Ulcers
Interventions: Not listed
Lead sponsor: Solsys Medical LLC; Industry
Eligibility: 21 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2026
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Ulcerative Colitis
Interventions: Ozanimod, Placebo; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years to 73 Years
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 10
States / cities: Anaheim, California • La Jolla, California • Oceanside, California + 7 more

Conditions: Ulcerative Colitis
Interventions: SER-287, Placebo, Placebo Pre-Treat, Vancomycin Pre-Treat; Drug
Lead sponsor: Seres Therapeutics, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Marlborough, Massachusetts

Conditions: Diabetic Foot Ulcers, Osteomyelitis
Interventions: DFU; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Ulcerative Colitis
Interventions: vedolizumab, Placebo; Drug · Other
Lead sponsor: Millennium Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 895 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 102
States / cities: Birmingham, Alabama • Los Angeles, California • Montebello, California + 82 more

Conditions: Ulcerative Colitis
Interventions: GB004, Placebo; Drug
Lead sponsor: GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Monroe, Louisiana

Conditions: Diabetic Foot Ulcers
Interventions: PRP Concepts Fibrin Bio-Matrix, Usual and Customary Practice; Device · Other
Lead sponsor: PRP Concepts, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Pressure Injuries
Interventions: HeelMedix Basic & EHOB Waffle; Device
Lead sponsor: Medline Industries; Industry
Eligibility: 22 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Northfield, Illinois

Conditions: Diabetes Mellitus, Foot Ulcer
Interventions: RCW design form; Device
Lead sponsor: Rosalind Franklin University of Medicine and Science; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: North Chicago, Illinois

Search by objective public record fields.

Preventing Amputations by Tailored Risk-based Intervention to Optimize Therapy

Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center

An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy

NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis

Oral Care Program for Mouth Side Effects During Head and Neck Radiation Therapy

A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863

Effects of Photobiomodulation (PBM) on Pain After Presentation of Aphthous Ulcers in Pediatric Dental Patients

Mesalamine and Reproductive Health Study

Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower Extremities

Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis

Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics

A Comparison of Once a Day Dose Compared to 2 Doses/Day

Comparison of Human Allograft to Apligraf for Venous Leg Ulcers

Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis

UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

GB004 in Adult Subjects With Active Ulcerative Colitis

A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Non-Healing Diabetic Foot Ulcers

Evaluation of Two Heel Protection Devices to Assess Off-loading Via Pressure Mapping.

Impact of Removable Cast Walker Design on Usability for Patients With Diabetic Foot Ulcers